Diagnostic performance of Liver FibraChek Dx©, a blood-based test for the non-invasive detection of liver cirrhosis and cancer

Figure 1 Risk analysis for liver disease. A comprehensive risk score is calculated using the levels of 5 biomarkers [serum L-tyrosine, taurocholic acid (by Liver FibraChek Dx^©), alanine aminotransferase, aspartate aminotransferase, and platelet count] (by standard laboratory hematological assessments), and patient age. Risk scores are categorized into 4 quartile groups, with 0.0 indicating low risk of hepatic disease and 1.0 indicating maximum risk of serious liver disease.

Figure 2 Liver assay receiver operating curve characteristics. The high likelihood of identifying metabolic dysfunction-associated steatotic liver disease using the Liver FibraChek Dx^© + algorithm combination was demonstrated by an area under the receiver operating curve of 0.890 (95%CI: 0.776-1.000). The Liver FibraChek Dx^© + algorithm combination. ROC: Receiver operating curve.